Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in BCAX — Bicara Therapeutics Inc.

CIK 1446194 BALA CYNWYD, PA

Position in BCAX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$217,676
-$298,887 QoQ
Shares Held
10,944
-64.3% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BCAX Over Time

Shares Held

Position Value (USD)

Derivatives in BCAX

reported options exposure · as of Mar 31, 2026
CallValue
$839,358
CallShares
42,200
PutValue
$1,300,806
PutShares
65,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. BCAX ranks #285 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCAX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,300,806 65,400
2026-03-31 $217,676 10,944
2026-03-31 $839,358 42,200
2025-12-31 $1,023,264 60,800
2025-12-31 $516,563 30,693
2025-09-30 $205,270 13,000
2025-06-30 $401,773 43,248
2025-03-31 $324,473 24,902